TGFβR2 is a novel target of miR-194-3p in fibroblasts and is upregulated in response to Myo-sEVsHG/HL or diabetes, which is reversed by overexpression of miR-194-3p. This evidence concerns the gene TGFBR2 and diabetes mellitus.